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HNa b s t r a c t
Human parainﬂuenza virus type 3 (hPIV3) recognizes both a2,3- and a2,6-linked sialic acids,
whereas human parainﬂuenza virus type 1 (hPIV1) recognizes only a2,3-linked sialic acids. To iden-
tify amino acid residues that confer a2,6-linked sialic acid recognition of hPIV3, amino acid residues
in or neighboring the sialic acid binding pocket of the hPIV3 hemagglutinin–neuraminidase (HN)
glycoprotein were substituted for the corresponding residues of hPIV1 HN. Hemadsorption assay
with sialyl linkage-modiﬁed red blood cells indicated that amino acid residues at positions 275,
277, 372, and 426 contribute to a2,6-linked sialic acid recognition of the HN3 glycoprotein.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Human parainﬂuenza virus type 3 (hPIV3) and type 1 (hPIV1)
are respiratory pathogens that cause laryngotracheobronchitis
and bronchiolitis in infants and young children [1]. hPIV1 and
hPIV3, which belong to the genus Respirovirus in the family
Paramyxoviridae, have two envelope glycoproteins, hemagglutinin–
neuraminidase (HN) glycoprotein and fusion glycoprotein. Both
hPIVs bind to terminal sialic acids of glycoconjugates on the host
cell surface through the HN glycoprotein to initiate infection [2].
Sialic acids are typically found at the terminals of oligosaccha-
rides on gangliosides and glycoproteins. They are mainly linked
to the terminal galactose residue by a2,3- or a2,6-linkage [3].Virus binding speciﬁcity for each sialyl linkage is believed to be
one of major determinants of tissue tropism or virulence. Among
paramyxoviruses, Sendai virus binds to both gangliosides with
terminal a2,3- and a2,6-linked sialic acids [4]. Newcastle disease
virus has been suggested to use both a2,3- and a2,6-linked sialic
acids on N-linked glycoproteins as viral receptors [5]. However,
speciﬁc amino acid residues of paramyxoviruses that determine
the recognition for each sialyl linkage have not been identiﬁed.
Our previous studies showed that hPIV1 and hPIV3 have differ-
ent recognition speciﬁcities for terminal sialyl linkages: hPIV1 and
the hPIV1 HN (HN1) glycoprotein preferentially recognize a2,3-
linked sialic acids, whereas hPIV3 and the hPIV3 HN (HN3)
glycoprotein recognize both a2,3- and a2,6-linked sialic acids on
the host cell surfaces [6,7]. Elucidation of the mechanism of sialyl
linkage recognition is important for understanding cell and tissue
tropism of hPIVs. In this study, we identiﬁed amino acid residues
that confer the a2,6-linked sialic acid recognition of hPIV3.
Amino acid residues in or neighboring the sialic acid binding
pocket of the HN3 glycoprotein were substituted for the
corresponding residues of the HN1 glycoprotein. Recognition
activities for a2,6-linked sialic acid of these HN3 glycoproteins
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age-modiﬁed red blood cells (RBCs).
2. Materials and methods
2.1. Cells, viruses, and antibody
Lewis lung carcinoma-monkey kidney (LLC-MK2) cells were
maintained in Eagle’s minimum essential medium (MEM) supple-
mented with 5% heat-inactivated fetal bovine serum (FBS).
African green monkey kidney (COS-7) cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with
10% FBS. hPIV1 C35 strain and hPIV3 C243 strain were kindly pro-
vided by Allen Portner of St. Jude Children’s Research Hospital.
Both hPIVs were propagated in LLC-MK2 cells. Rabbit anti-hPIV3
antibody was prepared by immunization with hPIV3 C243 strain
as described previously and puriﬁed on a Protein G HiTrap™
Protein G HP (CE Healthcare Biosciences Corp., Piscataway, NJ,
USA) [7].
2.2. Preparation of sialyl linkage-modiﬁed red blood cells
Human RBCs were collected from a healthy adult and washed 3
times with phosphate-buffered saline (PBS; pH 7.2, 131 mM NaCl,
14 mM Na2HPO4 and 2.7 mM KCl) (native RBCs). AUSD-RBCs were
prepared from complete desialylation on native RBCs by incuba-
tion of 10% native RBCs with PBS containing 25 mU/ml of sialidase
from Arthrobacter ureafaciens (AUSD; Nacalai Tesque, Kyoto, Japan)
at 37 C for 2 h and then washing with PBS 5 times. 23SD-RBCs
were prepared from desialylation of a2,3-linked sialic acids on
native RBCs by incubation of 10% native RBCs with PBS containing
100 U/ml of cloned a2,3 neuraminidase from Salmonella typhimur-
ium LT2 (23SD; New England Biolabs Inc., Ipswich, MA, USA) and
5 mM CaCl2 at 37 C for 30, 45, or 60 min and then washing with
PBS 5 times. ST6-RBCs were prepared from resialylation of a2,
6-linked sialic acids on AUSD-RBCs by incubation of 10% AUSD-
RBCs with PBS containing 1.5 mg/ml of cytidine-50-monophos-
pho-N-acetylneuraminic acid sodium salt (CMP-Sia; Nacalai
Tesque, Kyoto, Japan) and 75 mU/ml of a2,6-sialyltransferase from
Photobacterium damselae (ST6; CosmoBio Co., Ltd., Tokyo, Japan) at
37 C for 17 h and then washing with PBS 5 times.
2.3. Quantitation of cell surface expression of HN3 glycoproteins
Expression vectors of mutated HN3 glycoprotein were con-
structed as described in Supplementary method 1. To quantify cell
surface expression (CSE) of wild-type (WT) and mutated HN3
glycoproteins, a 70% conﬂuent monolayer of COS-7 cells in a 24-
well plate was transfected with 500 ng of pCAGGS expression plas-
mid vectors containing the WT or mutated HN3 genes using the
transfection reagent TransIT-LT1 (Mirus, Madison, WI, USA)
according to the manufacturer’s instructions. The cells were also
mock-treated without plasmid vectors. After incubation at 37 C
for 6 h, the transfected cells were washed with PBS and then cul-
tured in a serum-free medium (Hybridoma-SFM; SFM, Invitrogen,
Corp., Carlsbad, CA, USA). After incubation at 37 C for 48 h, the
cells were harvested by treatment with 200 ll of 0.125% trypsin-
PBS. The cells were washed with PBS, incubated with rabbit anti-
hPIV3 antibody, and then incubated with tetramethylrhodamine
(TRITC)-conjugated goat anti-rabbit IgG antibody (Sigma–Aldrich,
St. Louis, MO, USA) for 30 min at 4 C. Fluorescence for cells was
measured with an excitation of the 488-nm line of an argon laser
on a FACSCanto II ﬂow cytometer (BD, Franklin Lakes, NJ, and
USA). At least 1  104 cells were analyzed for each sample. The
background detected in non-transfected cells was subtracted.2.4. Hemadsorption assay
To determine HAD activity of HN1 and HN3 glycoproteins, a 70%
conﬂuent monolayer of COS-7 cells in a 48-well plate was trans-
fected with 300 ng of pCAGGS plasmid vectors containing WT
HN1, WT HN3, or mutated HN3 genes. Cells were also mock-trea-
ted without plasmids vectors. After incubation at 37 C for 48 h, the
cells were washed with PBS and incubated with 0.5% native RBCs,
23SD-RBCs, AUSD-RBCs, or ST6-RBCs in SFM for 30 min on ice. The
cells were washed 3 times with SFM and incubated with 100 ll of
ultrapure water for 10 min on ice. Fifty microliters of the super-
natant was applied in a 96-well plate, and the amount of hemoglo-
bin was determined by measuring the absorbance at 415 nm [7].
The background detected in non-transfected cells was subtracted.
3. Results
3.1. Comparison of amino acid sequences of the sialic acid binding
pockets in HN1 and HN3 glycoproteins
The HN1 glycoprotein recognizes only a2,3-linked sialic acid,
but the HN3 glycoprotein recognizes both a2,3- and a2,6-linked
sialic acids [6,7], meaning that the HN3 glycoprotein, but not the
HN1 glycoprotein, has amino acid residues that interact with
a2,6-linked sialic acids in the binding pocket. As another explana-
tion for the lack of binding of the HN1 glycoprotein to a2,6-linked
sialic acids, some amino acids in the binding pocket of the HN1
glycoprotein might interfere with the ﬁt of the receptor moiety
of a2,6-linked sialic acids. For Fig. 1 showing the structure of the
HN3 glycoprotein [8], red amino acid residues in the receptor bind-
ing pocket directly interact with the sialic acid residue of the
receptor through a hydrogen bond. These amino acid resides are
conserved between the HN1 and NH3 glycoproteins. When amino
acid sequences of the HN3 glycoprotein were compared with those
of the HN1 glycoprotein, 9 amino acid differences between them
were found in or neighboring the sialic acid binding pocket.
These residues are colored in green in the structure of the HN3
glycoprotein shown in Fig. 1. These 9 amino acid residues of the
HN3 glycoprotein were substituted for those of the HN1 glycopro-
tein (T193L, Q215A, D275N/R277T, F372L, S408A, T426S, T475S,
and G529A, based on amino acid numbering of the HN3 glycopro-
tein) for changing sialic acid linkage binding speciﬁcity of the HN3
glycoprotein. Neighboring amino acid resides at positions 275 and
277 were simultaneously substituted.
3.2. HAD activity and CSE of amino acid-substituted HN3 glycoproteins
The effects of amino acid substitutions of HN3 glycoproteins
were evaluated by HAD activity and CSE. The HN3 glycoproteins
carrying Q215A, S408A, T475S, or G529A substitutions showed sig-
niﬁcant reduction of HAD activity and CSE (Fig. 2). These amino
acid substitutions were probably needed to maintain normal CSE
of the HN3 glycoprotein. T193L, D275N/R277T, F372L, or T426S
substitutions of the HN3 glycoproteins resulted in HAD activity
and CSE similar to those of the WT HN3 glycoprotein. These results
indicated that T193L, D275N/R277T, F372L, and T426S sub-
stitutions had little effect on the sialic acid binding afﬁnity of the
HN3 glycoprotein.
3.3. Alpha2,6-linked sialic acid recognition of amino acid-substituted
HN3 glycoproteins
Alpha2,6-linked sialic acid recognition of the amino acid-substi-
tuted HN3 glycoproteins was estimated by HAD assays with a2,3-
linked sialic acid-removed RBCs, 23SD-RBCs. Some 23SD-RBCs
Fig. 1. Locations of amino acid substitutions and the sialic acid binding pocket in
the HN3 glycoprotein. The three-dimensional structure of HN3 glycoprotein with
sialic acid (PDB ID: 1V3C) was shown by PyMOL software. There were 9 amino acid
residues that were different in sequences of the HN1 and HN3 glycoproteins in or
neighboring the sialic acid binding pocket (green residues). These 9 residues of the
HN3 glycoprotein (left of position numbers) were substituted for the corresponding
residues of the HN1 glycoprotein (right of position numbers). Red residues mean
that amino acids directly interacted with the sialic acid residue through a hydrogen
bond. Sialic acid is shown by a stick model in green.
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and a2,6-linked sialic acids) with 23SD that selectively removed
a2,3-linked sialic acids, for 30, 45, and 60 min. While the WT
HN1 glycoprotein hardly bound to 23SD-RBCs, the WT HN3
glycoprotein bound to 23SD-RBCs and retained 52% HAD activity
even for 23SD-RBCs after 60-min incubation with 23SD relative
to native RBCs. This result indicated that the WT HN3 glycoprotein
recognized a2,6-linked sialic acids that remained on the surface
23SD-RBCs after 23SD treatment but that the HN1 glycoprotein
did not (Fig. 3). This sialic acid recognition speciﬁcity coincides
with results of our previous study [7]. The HN3 glycoprotein carry-
ing the T193L substitution showed HAD activity similar to that of
the WT HN3 glycoprotein (52% HAD activity even for 23SD-RBCs
after 60-min incubation with 23SD). The HN3 glycoproteins with
D275N/R277T, F372L, and T426S substitutions showed HAD activ-
ity similar to that of the WT HN3 glycoprotein for native RBCs,
whereas these substitutions in the HN3 glycoproteins decreased
HAD activity for 23SD-RBCs (14%, 0%, and 5% HAD activity for
23SD-RBCs after 60-min incubation with 23SD, respectively), indi-
cating that these substitutions affected the a2,6-linked sialic acid
recognition of the WT HN3 glycoprotein. S408A, T475S, andFig. 2. HAD activity and CSE of amino acid-substituted HN3 glycoproteins. COS-7
cells were transfected with HN3 genes. CSE (ﬁlled column) was quantitated by ﬂow
cytometry with rabbit anti-hPIV3 antibody. HAD activity (gray column) was
determined by the amount of native RBCs adsorbed on the HN3 glycoprotein-
expressing cells. All data are represented as relative percentages to the WT HN3
glycoprotein.G529A substitutions also decreased HAD activity for native RBCs
and 23SD-RBCs compared to the HAD activity of the WT HN3
glycoprotein, probably due to reduction of CSE of the HN3
glycoprotein.
Alpha2,6-linked sialic acid recognition of amino acid-substi-
tuted HN3 glycoproteins was also estimated by HAD assays with
a2,6-linked sialic acid-resialylated RBCs, ST6-RBCs. ST6-RBCs were
prepared by treatment of native RBCs with AUSD, which removed
all terminal sialic acids (AUSD-RBCs), and then by treatment of
AUSD-RBCs with ST6, which speciﬁcally transferred a2,6-linked
sialic acids to the terminal galactose residues. HAD activities of
the HN3 glycoproteins for native RBCs and ST6-RBCs were
expressed as relative activity to that of the WT HN3 glycoprotein
for native RBCs. Again, the WT HN3 glycoprotein, but not the WT
HN1 glycoprotein, showed 65% HAD activity for ST6-RBCs relative
to that for native RBCs (Fig. 4). The HN3 glycoprotein carrying the
T193L substitution showed HAD activity similar to that of the WT
HN3 glycoprotein (65% HAD activity for ST6-RBCs). D275N/R277T,
F372L, and T426S substitutions had little effect on HAD activity for
native RBCs, whereas these substitutions resulted in reduction of
HAD activity (31% HAD activity for D275N/R277T and 27% HAD
activity for T426S) or loss of HAD activity (5% HAD activity for
F372L) for ST6-RBCs. All of the HN glycoproteins showed no HAD
activity for AUSD-RBCs (data not shown). These results indicated
that amino acid residues at positions 275, 277, 372, and 426 in
the sialic acid binding pocket were required for a2,6-linked sialic
acid recognition of the HN3 glycoprotein, with little effect on
a2,3-linked sialic acid recognition.
4. Discussion
Sialyl linkage recognition of hPIVs determines cell infectivity
[7]. Elucidation of the mechanism of sialyl linkage recognition is
important for understanding cell and tissue tropism. To identify
amino acid residues that confer a2,6-linked sialic acid recognition
to the HN3 glycoprotein, amino acid residues in or neighboring the
sialic acid binding pocket of the HN3 glycoprotein were substituted
for the corresponding residues of the HN1 glycoprotein. HN3
glycoproteins with Q215A, S408A, T475S, and G529A substitutions
signiﬁcantly decreased CSE of the HN3 glycoprotein, meaning that
these amino acid residues were needed to maintain normal CSE of
the HN3 glycoprotein. HN3 glycoproteins with D275N/R277T,
F372L, and T426S substitutions showed CSE and HAD activity for
native RBCs similar to that of the WT HN3 glycoprotein, whereas
these substitution resulted in reduction or loss of the binding
activity for a2,6-linked sialic acids on the surface of RBCs. Based
on these results, it is concluded that amino acid residues at posi-
tions 275, 277, 372, and 426 in the sialic acid binding pocket
are required for a2,6-linked sialic acid recognition of the HN3
glycoprotein.
Simulations of docking of the disaccharides of a2,3-linked and
a2,6-linked sialic acids with galactose to the HN3 glycoprotein
were performed to elucidate the key interactions between the sia-
lic acid and amino acid residues in the binding pocket of the HN3
glycoprotein. Our simulations predicted that a2,6-linked galactose
could be located in the neighborhood of amino acid residues at
positions 275, 277, and 372 (Supplementary Fig. 1) but that a2,3-
linked galactose could not (Supplementary Fig. 2). The amino acid
residues at positions 275, 277, and 372 may interact with or stabi-
lize a2,6-linked galactose in and neighboring the binding pocket of
the HN3 glycoprotein.
The amino acid residue at position 426 is located in the sialic
acid binding pocket of the HN3 glycoprotein neighboring C-9 of
sialic acid (Supplementary Figs. 1 and 2). In an inﬂuenza A virus
study, it was shown that amino acid residues in the sialic acid
binding pocket of the hemagglutinin glycoprotein regulate sialyl
Fig. 3. HAD activities of WT HN3, WT HN1, and amino acid-substituted HN3 glycoproteins for 23SD-RBCs. 23SD-RBCs were prepared by 23SD treatment of native RBCs for 30
(gray column), 45 (hatched column), or 60 min (empty column) at 37 C. HAD activities of HN3 and HN1 glycoproteins for native RBCs (ﬁlled column) and 23SD-RBCs are
represented as relative percentages to those of WT HN3 glycoprotein and WT HN1 glycoprotein for native RBCs, respectively.
Fig. 4. HAD activities of WT HN3, the WT HN1, and the amino acid-substituted HN3 glycoproteins for ST6-RBCs. ST6-RBCs were prepared by a2,6 linkage-speciﬁc
resialylation of AUSD-RBCs with ST6. HAD activities of HN3 and HN1 glycoproteins for ST6-RBCs are represented as relative percentages to those of WT HN3 and WT HN1
glycoproteins for native RBCs, respectively.
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hydroxyl group of sialic acid [9]. Similar to the hemagglutinin
glycoprotein, the amino acid residue of the HN3 glycoprotein at
position 426 may regulate sialyl linkage recognition in interacting
with the C-9 hydroxyl group of sialic acid.
Human trachea cells predominantly express a2,6-linked sialic
acids [3]. Alpha 2,6-linked sialic acid recognition is thought to be
related to the higher pathogenicity of hPIV3 than that of hPIV1.
An amino acid sequence comparison of the HN3 glycoproteins
deposited in Virus Pathogen Database and Analysis Resource [10]
showed that there were no amino acid substitutions at positions
275, 277, 372, and 426 of the HN3 glycoproteins from 260 strains
isolated over the past 10 years. This suggests that a2,6-linked sialic
acid recognition continues to be conserved among hPIV3 strains.
The present work is the ﬁrst study to identify amino acid residues
that determine sialyl linkage recognition in the paramyxovirus
receptor binding protein. Our ﬁndings will be helpful to reveal
the biological signiﬁcance of tropism and pathogenesis of hPIVs.
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